New drug research and development is very difficult, and there is a saying that "it takes an average of ten years and one billion dollars to develop a new drug". Traditional R&D is complicated and costs continue to rise.
With the emergence of new targets and technologies and the increasingly fierce competition in the pharmaceutical industry, how can companies avoid homogenization and differentiate themselves? In the face of the current unmet demand for clinical drugs, how can we find an innovative path of development that is in line with the characteristics of China-based and global-oriented? How to mobilize the strength of multiple parties in the process of clinical value-oriented new drug development to solve clinical pain points and make better treatment solutions more accessible?
In order to overcome these "fogs", the 3rd (Shanghai) Biopharmaceutical Innovators Summit was officially opened in Shanghai on March 3, 2022, co-organized by PHARNEX and
Chemenu Pharmaceuticals. The conference invited 50+ experts in the field of biopharmaceutical research, development, operation and BD/investment to attend the event, aiming to build a platform for biopharmaceutical upstream and downstream to exchange industry trends and focus on industry innovation, attracting many industry colleagues to discuss innovation strategies, trends, technologies and experiences in the biopharmaceutical industry.
The conference involved a full range of topics such as basic scientific research, innovative biologics, novel therapeutic solutions, innovative technology platforms, clinical development strategies and applications, focusing on the frontier areas of the industry, in-depth discussion of the latest developments in the biopharmaceutical industry, bringing a wonderful communication feast for guests and participants!
Welcome to visit our website, find the API products you want, and
leave us a message to get cooperation!